SCHEMBL8549160

SCHEMBL8549160

CCCOc1ccc2[nH]cc(CN(C)C)c2c1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.45
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45
HTR1A P08908 3/20 0.40
ALDH1A1 P00352 2/20 0.39
CYP2D6 P10635 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TLR7 Q9NYK1 2/20 0.38
HTR1B P28222 2/20 0.37
THRA P10827 1/20 0.37
THRB P10828 1/20 0.37
HTR1D P28221 1/20 0.36
SLC6A4 P31645 3/20 0.36
HTR6 P50406 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8549767 0.94 HTR2A (0.44) HTR2AHTR2CHTR2BHTR1AALDH1A1
SCHEMBL8545081 0.87 HTR1A (0.55) HTR2AHTR2CHTR2BHTR1ACYP2D6
SCHEMBL8546408 0.83 HTR1A (0.52) HTR2AHTR2CHTR2BHTR1AALDH1A1
SCHEMBL8544351 0.83 HTR2A (0.45) HTR2AHTR2CHTR2BHTR1AHTR1B
SCHEMBL8543442 0.82 HTR1A (0.54) HTR2AHTR2CHTR1ACYP2D6KDM4E
SCHEMBL8545281 0.81 HTR2A (0.56) HTR2AHTR2CHTR2BHTR1AALDH1A1
SCHEMBL8545440 0.81 HTR1A (0.55) HTR2AHTR2CHTR2BHTR1ACYP2D6
SCHEMBL8543561 0.81 HTR2A (0.46) HTR2AHTR2CHTR1AALDH1A1CYP2D6
SCHEMBL8544872 0.81 CSNK2A1 (0.38) HTR2AHTR1AALDH1A1CYP2D6KDM4E
Fumaric Acid SCHEMBL30011017 0.79 HTR1A (0.51) HTR2AHTR2CHTR2BHTR1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593513-B1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1998-10-28 EP disclosed
US-5571833-A TREATMENT OF MIGRAINE, PORTAL HYPERTENSION SMITHKLINE BEECHAM PLC (GB) 1996-11-05 US disclosed
EP-0593513-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1994-04-27 EP disclosed
WO-1993000333-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-01-07 WO disclosed